ScreenCell® logo
Request a Quote

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer

  • Prostate cancer
  • By : H I Scher, A J Armstrong, J D Schonhoft, A Gill, J L Zhao, E Barnett, E Carbone, J Lu, E S Antonarakis, J Luo, S Tagawa, C H Dos Anjos, Q Yang, D George, R Szmulewitz, D C Danila, R Wenstrup, M Gonen, S Halabi

DOI : 

PMID :

  • 33894633

Abstract

Non disponibles.

Keywords

  • CTC, prognosis, biomarker, prostate cancer

Share on

Navigation

Quel kit correspond à mon application ?

The latest articles.

Circulating Tumor Cells from Surgical Manipulation Predict Recurrence and Poor Prognosis in Non-Small Cell Lung Cancer

  • Akikazu Kawase, Keigo Sekihara, Noriyuki Matsutani, Masafumi Yamaguchi, Yujin Kudo, Makoto Endo, Tetsukan Woo, Yuichi Saito, Noriyoshi Sawabata
  • DOI : 10.3390/jcm14062070

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial

  • Rosie A Harris, Elizabeth A Stokes, Tim J P Batchelor, Eveline Internullo, Doug West, Simon Jordan, Andrew G Nicholson, Ian Paul, Charlotte Jacobs, Michael Shackcloth, Sarah Feeney, Vladimir Anikin, Niall McGonigle, Richard Steyn, Maninder Kalkat, Dionisios Stavroulias, May Havinden Williams, Syed Qadri, Karen Dobbs, Vipin Zamvar, Lucy Macdonald, Surinder Kaur, Chris A Rogers, Eric Lim; VIOLET trialists
  • DOI : 10.1016/j.lungcan.2024.108070

Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells

  • Narisorn Kongruttanachok, Yvon E Cayre, Hans Knecht, Sabine Mai
  • DOI : 10.1532/LH96.12023
Liquid biopsy for
enhancing patient care
through reliable CTC analysis
Request a quote
Request the brochure